Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: a report from The International DLBCL Rituximab-CHOP Consortium Program

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Shen, Q; Xu-Monette, ZY; Manyam, GC; Visco, C; Tzankov, A; Cao, X; Deng, L; Montes-Moreno, S; Dybkær, K; Chiu, A; Orazi, A; Zu, Y; Bhagat, G; Richards, KL; Hsi, ED; Choi, WWL; Han van Krieken, J; Huh, J; Ponzoni, M; Ferreri, AJM; Farnen, JP; Møller, MB; Winter, JN; Piris, MA; Medeiros, LJ; Young, KH

Published Date

  • June 2015

Published In

Volume / Issue

  • 15 /

Start / End Page

  • S220 - S221

Published By

International Standard Serial Number (ISSN)

  • 2152-2650

Digital Object Identifier (DOI)

  • 10.1016/j.clml.2015.04.096